Therapeutics

Lornoxicam

Tools

Back to the Top

Overview

Name: Lornoxicam
Therapy Type: Small Molecule
Target Type: Inflammation
Condition(s): Alzheimer's Disease, Mild Cognitive Impairment
U.S. FDA Status: Alzheimer's Disease (Discontinued), Mild Cognitive Impairment (Discontinued)
Company: JSW Lifesciences
Approved for: Pain in US

Background

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

References

No Available References

Further Reading

No Available Further Reading